A Phase II trial of docetaxel and carboplatin administered every two weeks as preoperative therapy for stage II or III breast cancer: NCCTG Study N0338
      QxMD      Google Scholar   
Citation:
Am. J. Clin. Oncol. vol 36 (6)
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Book Volume:
1
Parents:
409   650   666  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
N01 CA035431, U10 CA035269, CA-37404, CA-35431, U10 CA037404, CA-25224, P30 CA015083, U10 CA035431, CA-35269, U10 CA025224  
Corr. Author:
 
Authors:
                 
Networks:
 
Study
N0338
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
neoadjuvant, breast cancer, dose-dense, docetaxel, carboplatin